These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 24477403)
1. Integrin/Chemokine receptor interactions in the pathogenesis of experimental autoimmune encephalomyelitis. Banisadr G; Schwartz SR; Podojil JR; Piccinini LA; Lanker S; Miller SD; Miller RJ J Neuroimmune Pharmacol; 2014 Jun; 9(3):438-45. PubMed ID: 24477403 [TBL] [Abstract][Full Text] [Related]
2. Adhesion Molecule Profile and the Effect of Anti-VLA-4 mAb Treatment in Experimental Autoimmune Encephalomyelitis, a Mouse Model of Multiple Sclerosis. Pyka-Fościak G; Lis GJ; Litwin JA Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563027 [TBL] [Abstract][Full Text] [Related]
4. Signaling through three chemokine receptors triggers the migration of transplanted neural precursor cells in a model of multiple sclerosis. Cohen ME; Fainstein N; Lavon I; Ben-Hur T Stem Cell Res; 2014 Sep; 13(2):227-39. PubMed ID: 25086214 [TBL] [Abstract][Full Text] [Related]
5. Mobilization of myeloma cells involves SDF-1/CXCR4 signaling and downregulation of VLA-4. Gazitt Y; Akay C Stem Cells; 2004; 22(1):65-73. PubMed ID: 14688392 [TBL] [Abstract][Full Text] [Related]
6. Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis. Theien BE; Vanderlugt CL; Eagar TN; Nickerson-Nutter C; Nazareno R; Kuchroo VK; Miller SD J Clin Invest; 2001 Apr; 107(8):995-1006. PubMed ID: 11306603 [TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12. O'Boyle G; Mellor P; Kirby JA; Ali S FASEB J; 2009 Nov; 23(11):3906-16. PubMed ID: 19667120 [TBL] [Abstract][Full Text] [Related]
8. Crosstalk between CXCR4/stromal derived factor-1 and VLA-4/VCAM-1 pathways regulates neutrophil retention in the bone marrow. Petty JM; Lenox CC; Weiss DJ; Poynter ME; Suratt BT J Immunol; 2009 Jan; 182(1):604-12. PubMed ID: 19109194 [TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of modified peptide inhibitor of alpha4 integrins on experimental allergic encephalomyelitis in Lewis rats. van der Laan LJ; van der Goes A; Wauben MH; Ruuls SR; Döpp EA; De Groot CJ; Kuijpers TW; Elices MJ; Dijkstra CD J Neurosci Res; 2002 Jan; 67(2):191-9. PubMed ID: 11782963 [TBL] [Abstract][Full Text] [Related]
11. Pattern of CXCR7 Gene Expression in Mouse Brain Under Normal and Inflammatory Conditions. Banisadr G; Podojil JR; Miller SD; Miller RJ J Neuroimmune Pharmacol; 2016 Mar; 11(1):26-35. PubMed ID: 25997895 [TBL] [Abstract][Full Text] [Related]
12. Antibody to α4 integrin suppresses natural killer cells infiltration in central nervous system in experimental autoimmune encephalomyelitis. Gan Y; Liu R; Wu W; Bomprezzi R; Shi FD J Neuroimmunol; 2012 Jun; 247(1-2):9-15. PubMed ID: 22503411 [TBL] [Abstract][Full Text] [Related]
13. CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis. McCandless EE; Wang Q; Woerner BM; Harper JM; Klein RS J Immunol; 2006 Dec; 177(11):8053-64. PubMed ID: 17114479 [TBL] [Abstract][Full Text] [Related]
14. Progenitor cell mobilization and recruitment: SDF-1, CXCR4, α4-integrin, and c-kit. Cheng M; Qin G Prog Mol Biol Transl Sci; 2012; 111():243-64. PubMed ID: 22917234 [TBL] [Abstract][Full Text] [Related]
15. Tellurium compound AS101 ameliorates experimental autoimmune encephalomyelitis by VLA-4 inhibition and suppression of monocyte and T cell infiltration into the CNS. Lee JH; Halperin-Sheinfeld M; Baatar D; Mughal MR; Tae HJ; Kim JW; Carter A; Lustig A; Snir O; Lavie G; Okun E; Mattson MP; Sredni B; Taub DD Neuromolecular Med; 2014 Jun; 16(2):292-307. PubMed ID: 24272426 [TBL] [Abstract][Full Text] [Related]
16. Antagonism of the chemokine receptors CXCR3 and CXCR4 reduces the pathology of experimental autoimmune encephalomyelitis. Kohler RE; Comerford I; Townley S; Haylock-Jacobs S; Clark-Lewis I; McColl SR Brain Pathol; 2008 Oct; 18(4):504-16. PubMed ID: 18422759 [TBL] [Abstract][Full Text] [Related]
17. Truncation of CXCL12 by CD26 reduces its CXC chemokine receptor 4- and atypical chemokine receptor 3-dependent activity on endothelial cells and lymphocytes. Janssens R; Mortier A; Boff D; Ruytinx P; Gouwy M; Vantilt B; Larsen O; Daugvilaite V; Rosenkilde MM; Parmentier M; Noppen S; Liekens S; Van Damme J; Struyf S; Teixeira MM; Amaral FA; Proost P Biochem Pharmacol; 2017 May; 132():92-101. PubMed ID: 28322746 [TBL] [Abstract][Full Text] [Related]
18. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis. Matejuk A; Bakke AC; Hopke C; Dwyer J; Vandenbark AA; Offner H J Neurosci Res; 2004 Jul; 77(1):119-26. PubMed ID: 15197745 [TBL] [Abstract][Full Text] [Related]
19. Kinin B2 receptor regulates chemokines CCL2 and CCL5 expression and modulates leukocyte recruitment and pathology in experimental autoimmune encephalomyelitis (EAE) in mice. Dos Santos AC; Roffê E; Arantes RM; Juliano L; Pesquero JL; Pesquero JB; Bader M; Teixeira MM; Carvalho-Tavares J J Neuroinflammation; 2008 Nov; 5():49. PubMed ID: 18986535 [TBL] [Abstract][Full Text] [Related]
20. The chemokine receptor CXCR4 enhances integrin-mediated in vitro adhesion and facilitates engraftment of leukemic precursor-B cells in the bone marrow. Shen W; Bendall LJ; Gottlieb DJ; Bradstock KF Exp Hematol; 2001 Dec; 29(12):1439-47. PubMed ID: 11750103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]